4-OH-, and 4-oxo-DHA [53], while not yet shown to bemade by cancer cells, also activate PPARγ with greater potency (ED50'sof 13.4 and 7.8 μM inactivating a cellular PPARγreporter, resp). Here, PPARG is linked to cancer.